Works matching IS 00070920 AND DT 2022 AND VI 127 AND IP 8
Results: 22
Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A novel high-risk subpopulation identified by CTSL and ZBTB7B in gastric cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Response to: Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Possible mechanism for improving the endogenous immune system through the blockade of peripheral μ-opioid receptors by treatment with naldemedine.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Lipoprotein and metabolite associations to breast cancer risk in the HUNT2 study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: a Mendelian randomisation analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Patient attrition in Molecular Tumour Boards: a systematic review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Somatic mutations in DCC are associated with genomic instability and favourable outcomes in melanoma patients treated with immune checkpoint inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Recent insights into the effects of metabolism on breast cancer cell dormancy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Neuropeptide Y, a paracrine factor secreted by cancer cells, is an independent regulator of angiogenesis in colon cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of changes to the interscreening interval and faecal immunochemical test threshold in the national bowel cancer screening programme in England: results from the FIT pilot study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Thermal stress involved in TRPV2 promotes tumorigenesis through the pathways of HSP70/27 and PI3K/Akt/mTOR in esophageal squamous cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
- Published in:
- 2022
- By:
- Publication type:
- journal article